tirzepatide like mounjaro FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Mounjaro (Tirzepatide) for Medical Weight

McKinney, MD, a physician specializing in weight loss at Healthy Outlook

Many individuals report a noticeable reduction in "food noise," which allows users to focus on long-term health markers rather than immediate cravings

Physician oversight provides an additional layer of safety

Gullaksen S, Vernstrm L, Srensen SS et al (2023) Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: a prespecified secondary analysis of a randomised clinical trial

It is important to keep all this in perspective: while a link between semaglutide and vision loss has been identified, this side-effect remains rare